Patents by Inventor Fiorella Calanni

Fiorella Calanni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10258610
    Abstract: The invention relates generally to pharmaceutical compositions comprising rifaximin effective at treating vaginal infections, and in particular bacterial vaginosis. The pharmaceutical compositions comprising rifaximin granules are characterized in that they release rifaximin in the vagina in a controlled way. The present invention also relates to processes for preparation of the rifaximin pharmaceutical compositions and their use in the treatment of vaginal infections. Effective dosages and courses of treatment useful and effective at recovering from the disease and preventing any possible relapse are also provided.
    Type: Grant
    Filed: July 26, 2012
    Date of Patent: April 16, 2019
    Assignee: ALFASIGMA S.P.A.
    Inventors: Giuseppe Claudio Viscomi, Paola Maffei, Vittoria Lauro, Fiorella Calanni, Beatrice Vitali, Federica Cruciani
  • Publication number: 20160047819
    Abstract: Diagnostic methods for evaluating vaginal infections comprising the use of specific proteins are described. Also described here is the use of specific proteins in a diagnostic method for evaluating recovery from the infections following antibiotic treatment of vaginal infections and predicting the recovery and remission of the infection. Diagnostic methods involving the use of specific proteins for evaluating recovery from the vaginal infections following rifaximin treatment and predicting the recovery and remission of the infection are also described.
    Type: Application
    Filed: March 4, 2014
    Publication date: February 18, 2016
    Inventors: Giuseppe Claudio VISCOMI, Fiorella CALANNI, Beatrice VITALI, Federica CRUCIANI
  • Publication number: 20160038468
    Abstract: This disclosure relates to rifaximin—for use in the treatment of bacterial vaginal infections. The disclosure also relates to the use of rifaximin for treating infections characterized by the presence of bacteria that may be clindamycin and/or metronidazole resistant. The disclosure also relates to the use of rifaximin to treat patients with vaginal infections who have relapsed following prior treatment or who have bacteria resistant to antibiotics other than rifaximin.
    Type: Application
    Filed: March 3, 2014
    Publication date: February 11, 2016
    Inventors: Giuseppe Claudio VISCOMI, Fiorella CALANNI
  • Patent number: 8404704
    Abstract: The present invention relates to Rifaximin polymorphic forms ?, ? and ?, to their use in medicinal preparations for the oral or topical route and to therapeutic methods using them.
    Type: Grant
    Filed: March 4, 2011
    Date of Patent: March 26, 2013
    Assignee: Alfa Wassermann S.p.A.
    Inventors: Giuseppe Claudio Viscomi, Manuela Campana, Donatella Confortini, Miriam Barbanti, Fiorella Calanni
  • Publication number: 20130028971
    Abstract: The invention relates generally to pharmaceutical compositions comprising rifaximin effective at treating vaginal infections, and in particular bacterial vaginosis. The pharmaceutical compositions comprising rifaximin granules are characterized in that they release rifaximin in the vagina in a controlled way. The present invention also relates to processes for preparation of the rifaximin pharmaceutical compositions and their use in the treatment of vaginal infections. Effective dosages and courses of treatment useful and effective at recovering from the disease and preventing any possible relapse are also provided.
    Type: Application
    Filed: July 26, 2012
    Publication date: January 31, 2013
    Applicant: ALFA WASSERMANN S.P.A.
    Inventors: Giuseppe Claudio VISCOMI, Paola MAFFEI, Vittoria LAURO, Fiorella CALANNI, Beatrice VITALI, Federica CRUCIANI
  • Publication number: 20120059023
    Abstract: The present invention relates to Rifaximin polymorphic forms ?, ? and ?, to their use in medicinal preparations for the oral or topical route and to therapeutic methods using them.
    Type: Application
    Filed: March 4, 2011
    Publication date: March 8, 2012
    Applicant: ALFA WASSERMANN, S.P.A.
    Inventors: Giuseppe C. Viscomi, Manuela Campana, Donatella Confortini, Miriam Barbanti, Fiorella Calanni
  • Patent number: 7915275
    Abstract: The present invention relates to Rifaximin polymorphic forms ?, ? and ?, to their use in medicinal preparations for the oral or topical route and to therapeutic methods using them.
    Type: Grant
    Filed: October 17, 2007
    Date of Patent: March 29, 2011
    Assignee: Alfa Wassermann, S.p.A.
    Inventors: Giuseppe C. Viscomi, Manuela Campana, Donatella Confortini, Miriam Barbanti, Fiorella Calanni
  • Publication number: 20080132530
    Abstract: The present invention relates to Rifaximin polymorphic forms ?, ? and ?, to their use in medicinal preparations for the oral or topical route and to therapeutic methods using them.
    Type: Application
    Filed: October 17, 2007
    Publication date: June 5, 2008
    Applicant: ALFA WASSERMANN S.P.A.
    Inventors: Giuseppe C. Viscomi, Manuela Campana, Donatella Confortini, Miriam Barbanti, Fiorella Calanni